BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11672772)

  • 1. Translocation (14;19)(q32;q13) detected by spectral karyotyping and lack of BCL3 rearrangement in CD5-positive B-cell lymphoma associated with hemophagocytic syndrome.
    Yamamoto K; Nakamura Y; Arai H; Aoyagi M; Saito K; Furusawa S; Mitani K
    Cancer Genet Cytogenet; 2001 Oct; 130(1):38-41. PubMed ID: 11672772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.
    Michaux L; Mecucci C; Stul M; Wlodarska I; Hernandez JM; Meeus P; Michaux JL; Scheiff JM; Noël H; Louwagie A; Criel A; Boogaerts M; Van Orshoven A; Cassiman JJ; Van Den Berghe H
    Genes Chromosomes Cancer; 1996 Jan; 15(1):38-47. PubMed ID: 8824724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
    Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
    Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (11;14)(q13;q32) in CD5-positive B-cell lymphoma associated with haemophagocytic syndrome.
    Yamamoto K; Nagata K; Hamaguchi H
    Br J Haematol; 1999 Sep; 106(4):1069-70. PubMed ID: 10520018
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS.
    Shimazaki C; Inaba T; Okano A; Hatsuse M; Takahashi R; Hirai H; Sudo Y; Ashihara E; Adachi Y; Murakami S; Saigo K; Tsuda H; Fujita N; Nakagawa M
    Intern Med; 2001 Sep; 40(9):878-82. PubMed ID: 11579948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic small B-cell lymphoma with IGH/BCL3 translocation.
    Soma LA; Gollin SM; Remstein ED; Ketterling RP; Flynn HC; Rajasenan KK; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):218-30. PubMed ID: 16426923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.
    Martín-Subero JI; Ibbotson R; Klapper W; Michaux L; Callet-Bauchu E; Berger F; Calasanz MJ; De Wolf-Peeters C; Dyer MJ; Felman P; Gardiner A; Gascoyne RD; Gesk S; Harder L; Horsman DE; Kneba M; Küppers R; Majid A; Parry-Jones N; Ritgen M; Salido M; Solé F; Thiel G; Wacker HH; Oscier D; Wlodarska I; Siebert R
    Leukemia; 2007 Jul; 21(7):1532-44. PubMed ID: 17495977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
    McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
    Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
    Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
    [No Abstract]   [Full Text] [Related]  

  • 10. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
    Huh YO; Abruzzo LV; Rassidakis GZ; Parry-Jones N; Schlette E; Brito-Bapabulle V; Matutes E; Wotherspoon A; Keating MJ; Medeiros LJ; Catovsky D
    Br J Haematol; 2007 Jan; 136(2):220-8. PubMed ID: 17129229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular large B-cell lymphoma associated with t(14;19)(q32;q13) translocation.
    Kobayashi T; Ohno H
    Intern Med; 2011; 50(18):2007-10. PubMed ID: 21921386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal t(14;19)(q32.3;q13.1) in a patient with B-cell lymphoma.
    Tanaka S; Nishigaki H; Nakagawa H; Okuda T; Nishida K; Tsuda S; Taniwaki M; Imanishi H; Misawa S; Kashima K
    Cancer Genet Cytogenet; 1990 Oct; 49(2):219-24. PubMed ID: 2208056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma?
    Daniel MT; Tigaud I; Flexor MA; Nogueira ME; Berger R; Jonveaux P
    Br J Haematol; 1995 May; 90(1):77-84. PubMed ID: 7786799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate lymphocytic lymphoma with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2).
    Nakagawa M; Sugiyama H; Ogawa H; Tone S; Morishita H; Ikeda H; Aozasa K; Taniwaki M; Abe T; Kishimoto T
    Cancer Genet Cytogenet; 1995 Jan; 79(1):89-91. PubMed ID: 7850761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphoma-associated hemophagocytic syndrome.
    Shimazaki C; Inaba T; Nakagawa M
    Leuk Lymphoma; 2000 Jun; 38(1-2):121-30. PubMed ID: 10811454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics.
    Miyahara M; Sano M; Shibata K; Matsuzaki M; Ibaraki K; Shimamoto Y; Tokunaga O
    Ann Hematol; 2000 Jul; 79(7):378-88. PubMed ID: 10965786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.